Press releases
Stay informed about the latest developments and official statements in the cannabis industry with Business of Cannabis' collection of press releases. Learn about new products, industry news and more from top companies.
Press releases · page 17
- CBD Market
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK And EU Market Position
PRESS RELEASE 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the acquisition of privately held RX Pharmatech Ltd (RXP), a leading United Kingdom distributor of cannabinoids with 1,276 novel food applications with the U.K.
- Cultivation
Hellenic Dynamics ‘On Track’ To Supply Flowers To Germany By Mid 2023
PRESS RELEASE Hellenic Dynamics’ core strategy is to develop and operate its 40,000 square metre active THC cultivation licence from its 195,506 square metre facility located near Thessaloniki in Northern Greece.
- Press releases
Key NHS Cannabis Project To Kick Off
PRESS RELEASE Key NHS cannabis project to kick off A key project developing a flexible health economics analysis tool to evaluate the potential of cannabis prescriptions on the NHS is set to kick off, after funding was secured from a range of backers.
- Press releases
NHS Reimburses The Cost Of Cannabis Treatment To The First Zerenia Clinics UK Patient
PRESS RELEASE KHIRON Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), continues to spearhead the medical cannabis market in the United Kingdom by successfully attaining, for the first time, full reimbursement by the NHS of costs associated to cannabis-based medication and clinic fees for a patient enrolled in Zerenia™ Clinics UK.
- Press releases
Chanelle McCoy Granted Approval For Significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial
PRESS RELEASE R&D Pharmaceutical company, Chanelle McCoy Health, founded by Lady Chanelle McCoy and Caroline Glynn, are pleased to announce they have received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
- Press releases
Stenocare AS Delivered Products To Its 5 Markets During Q4 2022 Corresponding To Net Sales Of 2.8m DKK And Is On Track For Its Sales Expectations For 2023 In The Range Of 15-20m DKK
PRESS RELEASE STENOCARE entered three new countries during 2022, and thereby expanded their market presence to five countries with prescription-based medical cannabis oil products approved for sale.
- Press releases
Royal Queen Seeds Launches The First Ever F1 Hybrid Seeds Into The Cannabis Market
PRESS RELEASE ONE of Europe’s leading cannabis seed banks, Royal Queen Seeds, just became the first company to offer true F1 cannabis hybrids with the uniformity, stability, and yield quality needed by the budding legal cannabis industry.
- Press releases
Polish Cannabis Biotech Company Healthcann Now Looking For Investors
PRESS RELEASE Healthcann – the first Polish hemp biotech company – has launched a crowdfunding.
- Press releases
MGC Pharmaceuticals Ltd Delivery of US$1 Million Order Of ArtemiC To AMC Holdings completed
PRESS RELEASE MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’) a European based pharmaceutical company specialising in the production and development of plant inspired medicines, is pleased to announce that it has completed the delivery of its largest order of ArtemiC to US distribution and marketing partner, AMC Holdings Inc.
- Press releases
New Offering For The CBD Industry Developed By The CIC
PRESS RELEASE The Cannabis Industry Council (CIC) has developed a new offering for CBD companies, in order to better represent the interests of this important sector.
- Press releases
Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API
PRESS RELEASE BRAINS Bioceutical Corp (“Brains Bio” or the “Company”), a global leader in EU GMP grade Cannabidiol (CBD) has received NSF GMP certification (NSF/ANSI 173, Section 8) for its EU GMP manufacturing facility in the UK.
- Press releases
UK’s Leading Medical Cannabis Company, Lyphe Group, To Distribute Across The Globe In New Exclusive Deal
PRESS RELEASE Lyphe Group, the UK’s leading medical cannabis company, has announced an exclusive partnership with Cronos Australia Limited’s (“Cronos”) wholly-owned subsidiary Burleigh Heads Cannabis Pty Ltd (“BHC”).
